Pharmacognostic Studies and Evaluation of Antidiabetic activity of Crotalaria verrucosa

 

M. Sandeep Kumar1*, G Varun1, P Swetha1, K UdaySasi Kiran2

1Dept. of Pharmaceutical Sciences, Vishnu Institute of Pharmaceutical Education and Research, Narsapur, AP, India.

2Dept. of Pharmacology, Royal College of Pharmacy and Health Sciences, Berhampur, Odisha.

*Corresponding Author E-mail: . msk.sunny27@gmail.com

 

 

ABSTRACT:

In this study, the crude ethanolic extract of Crotolaria verrucosa were evaluated for possible anti-diabetic activity by conducting in vitro experiments on alloxan induced diabetic albino rats. Various concentrations of three dose levels (200 mg/ kg, 100 mg/ kg, 400 mg/ kg) of the crude extract were tested for the anti-diabetic activity. With higher doses (400mg/kg), the crude extract exhibited significantly comparable results with the standard drug Glibenclamide. The results show that the alcoholic extract of Crotolaria verrucosa possess substantial anti-diabetic activity, thus may be effectively used in treatment of diabetes. Preliminary phytochemical analyses of the alcoholic extract revealed the presence of alkaloids, flavonoids, carbohydrates, terpenoids and glycosides. The total content of alkaloids, flavonoids and phenols were 8.26% (w/w), 35.1mg quercetin equivalent and 17.8mg pyrocatachol equivalent respectively.

 

KEYWORDS: Diabetes, anti-diabetic, Crotolaria verrucosa, Glibenclamide, alloxan.

 


1. INTRODUCTION:

Diabetes mellitus is a chronic metabolic disorder affecting millions of individual worldwide characterized by hyperglycemia due to inherited or acquired deficiency in the production of insulin in turn resulting in complications associated with neurological, cardiovascular, retinal and renal disorders. There are an estimated 2.85 billion adults with diabetes in 2010 and this number will continue to increase globally due to an aging population, growth of population size, urbanization, high prevalence of obesity and sedentary lifestyle.1,2 The treatment with modern medicines such as insulin therapy, sulfonylureas, thiazolidinediones, biguanides, meglitimides, and etc., mostly associated with the side effects. To overcome the toxic effects caused by these drugs an alternative system of treatment is required. Therefore, it is crucial to search the necessary potential in herbal medicines.3 Moreover, medicinal plant extracts have been used by indigenous people to treat various ailments, including infectious diseases4. In view of this, we investigated a medicinal plant which is claimed to possess anti-diabetic activity.

 

Crotolaria verrucosa commonly called as “Blueflower Rattlepod” belongs to the family Fabaceae is an erect much branched herb. This plant is widely distributed in South Asia, Australia.5

 

In India it is used ethno medically in the treatment of diarrhea, diabetes, leprosy, and migraine. The literature survey reveals that no reports were found on the anthelmintic activity of crude extract of Crotolaria verrucosa. 6Therefore the current study was performed to evaluate the in vitro anthelmintic activity of crude extract of Crotolaria verrucosa against alloxan induced diabetic albino rats.

 

2. MATERIALS AND METHODS:

2.1 Chemicals

Alloxan was purchased from Crescent Trading Company, Hyderabad. Glibenclamide was obtained as a gift sample from Arandy Laboratories Ltd, Hyderabad. All other chemical and reagents used were of analytical grade.

 

2.2 Preparation of plant extract

The dried powder of C. verrucosa whole plant was extracted with Ethanol (80%) by soxhlation process. The filtrates were concentrated at reduced pressure by Rotary Falsh Vaccum Evaporator.7

 

2.3 Qualitative Phytochemical Studies

In order to determine the presence of alkaloids, glycosides, flavones, tannins, terpenes, sterols, saponins, and sugars, a preliminary phytochemical study (color reactions) with various plant extracts was performed.8,9

 

 

2.4 Quantitative screening

2.4.1 Determination of Alkaloid content [10]

Alkaloids were quantitatively determined according to the method described by Harbone. 200 mL of 10% acetic acid in ethanol was added to 5 g of powdered sample and allowed to stand for about 4 hours. The filtrate was then concentrated to 1/4th of its original volume. Further, concentrated ammonium hydroxide was added in drop by drop manner to the extract until the precipitation was complete. Then, the whole solution was allowed to settle and the obtained precipitates were washed with dilute ammonium hydroxide and filtered. Finally, the alkaloid residue was dried, weighed and expressed quantitatively.

 

2.4.2 Determination of Flavonoid content [11,12]

The total flavonoid content was quantitatively determined according to the Dowd method. 5mL of 2% aluminium trichloride (AlCl3) in methanol was mixed with equal volume of the extract solution (0.3mg/mL). The same solution was placed in a cuvette and absorption was read at 415 nm using Shimoda UV-Visible spectrophotometer. Prior, blank solution absorption was measured consisting of 5mL of the extract solution and 5mL of methanol without AlCl3. The total flavonoid content was determined using a standard curve plotted with quercetin (1-100mg/L) as the standard. Total flavonoid content is expressed as quercetin equivalents (QE)/g of the extract.

 

2.4.3 Determination of Total Phenolic content[13]

The total phenolic content was quantitatively determined according to the Folin-Ciocalteu method described by Cheung et al. and Singleton et al. Briefly, 0.02mL of extract of different concentrations (4, 8, 12, 16 and 20mg/ml) and control (methanol) were mixed with 1.58 ml of distilled water. Then, 0.1 ml of Folin-Ciocalteu’s phenol reagent was added to each test tube. After 3 min, 3ml of Na2CO3 (2%) was added and the mixture was shaken on a shaker for about 2 hours at room temperature. Finally, absorbance was determined at 765 nm with a Shimoda UV-Visible spectrophotometer. All assays were conducted in triplicate and the results were averaged. A dose response linear regression was generated by using the pyrocatachol standard absorbance and the levels in the samples were expressed as pyrocatachol equivalents (mg of PAEs/g of extract).

 

2.4 Experimental Animals

Healthy albino Wistar rats (200–225 g) of either sex were housed in polypropylene cages lined with husk in standard environmental conditions. The rats were fed on a standard pellet diet ad libitum and had free access to water (Turner .A, 2009). The experiments were performed after approval of the protocol by the Institutional Animal Ethics Committee (IAEC) and were carried out in accordance with the current guidelines for the care of laboratory animals.

 

2.5 Experimental Design

Antidiabetic activity of C. verrucosa ethanolic extract was assessed in normal, and alloxan induced diabetic rats (Thirupathi Reddy et al., 2006). In all studies, the animals were fasted overnight for 16hrs with free access to water throughout the duration of experiment.

 

2.5.1   Acute Toxicity Studies

Acute toxicity of C. verrucosa ethanolic extract was performed on albino rats, according to OECD Guidelines 425. The first group was treated after fasting overnight with a oral dose of 1000 mg/ kg of body weight with the ethanolic extract of the plant “C. verrucosa”, suspended in 0.6 % Na CMC. And extracts were given in two different groups. And the animals were observed continuously for 2-3 hrs for general behavioral, and finally death after 24 hrs. There was no mortality and no signs of toxicity and the extracts were found to be safe at this dose level. A higher dose of 2000 mg/ kg body weight of the ethanolic extract of whole plant. For the assessment of all the biological activities, three dose levels (200 mg/ kg, 100 mg/ kg, 400 mg/ kg) were chosen.

 

2.5.2   Evaluation of extract in Alloxan- induced diabetic rats

Diabetes was induced in rats by injecting 120 mg/kg of Alloxan monohydrate intraperitoneally in 0.6% w/v CMC to overnight-fasted rats. After 72 h of injection, fasting blood glucose level was measured. The animals that did not develop more than 200 mg/dl glucose levels were rejected. The selected diabetic animals were divided into five groups (n = 6) and one more group of normal non-alloxanised animals was also added to the study. Group 1 was kept as normal control (non-alloxanised rats), which received a single dose of 0.5 ml/100 g of the vehicle; Group 2 was kept as negative control, alloxan induced and received a single dose of 0.5 ml/100 g of the vehicle; group 3, 4, and 5, diabetic induced were treated with ethanolic extract that exhibited antidiabetic activity at three dose levels (100mg/kg, 200mg/kg, 400mg/kg); Group 2 was kept as negative control, alloxan induced and received a single dose of 0.5 ml/100 g of the vehicle. The treatment was continued for 7 consecutive days (p.o). at the end of 7th day, the rats were fasted for 16h and blood parameters were determined.14The determination of blood glucose levels is done by tail tipping method using Accuchek-sensor glucometer. After 7 days blood is collected by Tail – Cut method to measure blood glucose levels.15

 

3.   RESULTS AND DISCUSSIONS:

The percentage yields of ethanol extract were found to be 10% w/w respectively. Preliminary phytochemical analysis showed the presence of alkaloids, terpenoids, flavonoids, carbohydrates and glycosides. Quantitative determination was performed for alkaloids, flavonoids and phenols. Alkaloids content was determined according to Harborne method and the amount of total alkaloids content was found to be 8.26% (w/w). Flavonoids are large class of benzo-pyrone derivatives and their total content was estimated by Dowd method. The total flavonoid content was found to be 35.1mg quercetin equivalent. Total phenolic content assay was performed as described by Slinkard- Singleton method and found to be 17.8mg pyrocatachol equivalent.

 


Table 1: Antidiabetic Activity of ethanolic extract of C.verrucosa

 

1st Day

3rd  Day

7th Day

Normal Control

106.33 + 3.84

109.83 + 4.56

112.7 + 2.16

Diabetic Control

252.08 + 3.51

249.002 + 4.21

248.67 + 1.065

Ethanolic Extract (100 mg/Kg)

251.83 + 3.15

231.50 + 4.023*

212.17 + 4.70 **

Ethanolic Extract (200 mg/Kg)

243.02 + 2.68 *

212.17 + 3.416 **

182.50 + 1.035 **

Ethanolic Extract (400 mg/Kg)

248.50 + 1.256**

198.004 + 2.64***

139.64 + 2.49 ***

Standard(Glibenclamide 5 mg/kg)

211+ 3.114**

151.17+ 4.325***

 117.864 + 3.169***

*P <0.05, **P< 0.01, ***P <0.001 was considered significant comparing to the Diabetic controlled group.

 


The present study was undertaken to evaluate the antidiabetic activity of ethanolic extract of C. verrucosa. Alloxan induced hyperglycemia in rodents is considered to be a good preliminary screening model and is widely used. Alloxan causes diabetes through its ability to destroy the insulin-producing beta cells of the pancreas. In vitro studies have shown that alloxan is selectively toxic to pancreatic beta cells, leading to the induction of cell necrosis. The cytotoxic action of alloxan is mediated by reactive oxygen species, with a simultaneous massive increase in cytosolic calcium concentration, leading to a rapid destruction of beta cells.

 

Experimental studies revels that the ethanolic extract from C. verrucosa whole plant (400 mg/kg) orally administered for 7 days produced a significant decrease in the blood glucose level in the model of alloxan-induced diabetes in rats. It also proves the traditional claim with regard to C. verrucosa for its anti-diabetic activity. Thus, the significant antidiabetic effect of C. verrucosa ethanolic extract could be due to the presence of various phytoconstituents detected in the phytochemical screening which alone or in synergism can impart therapeutic effect. Majorly, due to the presence of alkaloids in the crude extract might be the reason for the effective hypoglycemic activity of the crude extract of C. verrucosa.

 

4. CONCLUSION:

The present investigation clearly reveals the indigenous system of medicine claim of the importance of C. verrucosa as an economical antidiabetic agent. The plant bears a potential for further research to isolate anti-diabetic principle. Further extended research may include isolating and characterizing the active constituent present in the crude extract and also to investigate its mechanism of action.

 

REFERENCES:

1.       Didem DO, Mustafa A, Nilufer S, et. al. Evaluation of the hypoglycemic effect and antioxidant activity of three Viscum album subspecies (European mistletoe) in Streptozotocin-diabetic rats. Journal of Ethanopharmacology.98;2005: 95-102.

2.       Ayeesha N, Gunasekaran S, Soosai MA, et. al. Antidiabetic activity of Aloe vera and histology of organs in STZ-induced diabetic rats.Current Sciences. 94; 2008:1070-1076.

3.       Ajay KS, Jyothi S. Evaluation of anti-diabetic potential of leaves and stem of Flacourtiajangomas in Streptozotocin-induced diabetic rats.Indian Journal of Pharmacology. 42; 2011: 301-305.

4.       Kightlinger LK, Seed JR, Kightlinger MB. The epidemiology of Ascarislumbicoides, Trichuristrichiura, and hookworm in children in the Ranomafana rainforest, Madagascar. Journal of Parasitology. 81; 1995: 159–169.

5.       Meena K, Eesha BR, Mohanbabu A, Sarathbabu, Rajshekar, Neelesh K. Wound healing activity of aqueous extract of Crotalaria verrucosa in Wistar albino rats. Asian Pacific Journal of Tropical Medicine. 3(10);  2010: 783-787. 

6.       Subodh KS, Pradeepa MS, Chetana H, Neelam R, Veerana GA. Antifertility Effect of Aerial Part of Crotalaria Verrucosa in Female Albino Rats. Pharmacologyonline. 3; 2011: 700-720.

7.       Raphael Ikan, Natural Products, A Laboratory Guide, 2nd edition, Elsevier India, 2009, 29 – 58.

8.       Rangari VD. Pharmacognosy and Phytochemistry part-II, 3rd edition. Career Publications,Nashik.2003, 87-88.

9.       Raaman N. Phytochemical Techniques, 2nd edition, New India Publishing Agency, New Delhi, 2006, 12-24.

10.     Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian Medicinal Plants. African Journal of Biotechnology. 4 (7); 2005: 685-688.

11.     Ghafar MF, Prasad KN, Weng KK, Ismail A. Flavonoid, hesperidine, total phenolic contents and antioxidant activity from Citrus species. African Journal of Biotechnology. 9 (3); 2010: 326-330.

12.     Naskar S, Islam A, Mazumder UK., Saha P, Haldar PK., Gupta M. In Vitro Antioxidant Potential of Hydromethanolic Extract of Phoenix dactylifera Fruits. Journal of Scientific Research. 2 (1); 2010: 144-157.

13.     Zivkovic J, Mujic I, Zekoviv Z, Nikolic G, Vidovic S, Mujic A., Extraction and Analysis of Condensed Tannins in Castanea sativa Mill., Journal of Central European Agriculture. 10 (3); 2009: 283-288.

14.     Duganath N, Rama Krishna D, Deepak Reddy G, Sudheera B, Mallikarjun M, Pavani B. Evaluation of anti-diabetic activity of Triumfettarhomboidea in alloxan induced Wistar rats. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2(1); 2011: 721-726.

15.     Lenzen S. The mechanism of alloxan and streptozotocine inducelod diabetes. Diabetologia. 51; 2008: 216 – 226.

 

 

 

 

Received on 10.10.2013       Modified on 25.10.2013

Accepted on 01.11.2013      © RJPT All right reserved

Research J. Pharm. and Tech. 7(1): Jan. 2014; Page 20-22